Book contents
- CASE STUDIES Stahl’s Essential Psychopharmacology
- Reviews
- CASE STUDIES: Stahl’s Essential Psychopharmacology
- Copyright page
- Contents
- Introduction
- List of icons
- Abbreviations
- Case 1: The salutatorian who couldn’t speak: selective serotonin reuptake inhibitor (SSRI)-refractory anxiety in an adolescent
- Case 2: From anxious to activated: selective serotonin reuptake inhibitor (SSRI)-related activation
- Case 3: The girl who couldn’t sleep: posttraumatic stress disorder (PTSD) in a young girl
- Case 4: Depressed and still depressed: major depressive disorder (MDD) in an adolescent
- Case 5: A 13-year-old adolescent who feels “amazing”: selective serotonin reuptake inhibitor (SSRI)-induced mania in an adolescent
- Case 6: Counting on a cure: obsessive compulsive disorder (OCD) in an adolescent
- Case 7: Struggles in the second grade: attention-deficit hyperactivity disorder (ADHD) in a child
- Case 8: From prodrome to psychosis: early-onset schizophrenia
- Case 9: Too much, too little, or just right? Lithium dosing in an adolescent
- Case 10: Tic, tic, tic: motor and vocal tics in a boy
- Case 11: How slow can you go? Selective serotonin reuptake inhibitor (SSRI) withdrawal and discontinuation in an adolescent
- Case 12: The adolescent who doesn’t eat: anorexia nervosa in an adolescent
- Case 13: High or higher antidepressant concentrations? Cannabis-related drug interactions in an adolescent
- Case 14: The boy whose bed was always wet: nocturnal enuresis in a child
- Case 15: Counting sheep and counting treatment trials: insomnia disorder in an adolescent
- Case 16: Second-generation antipsychotics/mixed dopamine–serotonin receptor agonists (SGAs), side effects, and the autism spectrum: SGA-related side effects in a boy with autism spectrum disorder (ASD)
- Case 17: The “standard treatment” is earning a “D”: treatment-resistant schizophrenia
- Case 18: Symptoms, side effects, or both? Selective serotonin reuptake inhibitor (SSRI) tolerability and physical symptoms in an anxious adolescent
- Book part
- Case Studies Index
- Drugs Index
- References
Case 3: The girl who couldn’t sleep: posttraumatic stress disorder (PTSD) in a young girl
Published online by Cambridge University Press: 09 February 2024
Book contents
- CASE STUDIES Stahl’s Essential Psychopharmacology
- Reviews
- CASE STUDIES: Stahl’s Essential Psychopharmacology
- Copyright page
- Contents
- Introduction
- List of icons
- Abbreviations
- Case 1: The salutatorian who couldn’t speak: selective serotonin reuptake inhibitor (SSRI)-refractory anxiety in an adolescent
- Case 2: From anxious to activated: selective serotonin reuptake inhibitor (SSRI)-related activation
- Case 3: The girl who couldn’t sleep: posttraumatic stress disorder (PTSD) in a young girl
- Case 4: Depressed and still depressed: major depressive disorder (MDD) in an adolescent
- Case 5: A 13-year-old adolescent who feels “amazing”: selective serotonin reuptake inhibitor (SSRI)-induced mania in an adolescent
- Case 6: Counting on a cure: obsessive compulsive disorder (OCD) in an adolescent
- Case 7: Struggles in the second grade: attention-deficit hyperactivity disorder (ADHD) in a child
- Case 8: From prodrome to psychosis: early-onset schizophrenia
- Case 9: Too much, too little, or just right? Lithium dosing in an adolescent
- Case 10: Tic, tic, tic: motor and vocal tics in a boy
- Case 11: How slow can you go? Selective serotonin reuptake inhibitor (SSRI) withdrawal and discontinuation in an adolescent
- Case 12: The adolescent who doesn’t eat: anorexia nervosa in an adolescent
- Case 13: High or higher antidepressant concentrations? Cannabis-related drug interactions in an adolescent
- Case 14: The boy whose bed was always wet: nocturnal enuresis in a child
- Case 15: Counting sheep and counting treatment trials: insomnia disorder in an adolescent
- Case 16: Second-generation antipsychotics/mixed dopamine–serotonin receptor agonists (SGAs), side effects, and the autism spectrum: SGA-related side effects in a boy with autism spectrum disorder (ASD)
- Case 17: The “standard treatment” is earning a “D”: treatment-resistant schizophrenia
- Case 18: Symptoms, side effects, or both? Selective serotonin reuptake inhibitor (SSRI) tolerability and physical symptoms in an anxious adolescent
- Book part
- Case Studies Index
- Drugs Index
- References
Summary
Which of the following represents an evidence-based intervention for a child with PTSD and prominent intrusive symptoms?
- Type
- Chapter
- Information
- Case Studies: Stahl's Essential PsychopharmacologyChildren and Adolescents, pp. 35 - 48Publisher: Cambridge University PressPrint publication year: 2023
References
Cohen, J. A., Scheeringa, M. S. Post-traumatic stress disorder diagnosis in children: challenges and promises. Dialogues Clin Neurosci 2009; 11: 91–9. https://doi.org/10.31887/dcns.2009.11.1/jacohenGoogle Scholar
Cohen, J. A., Mannarino, A. P., Perel, J. M., Staron, V. A pilot randomized controlled trial of combined trauma-focused CBT and sertraline for childhood PTSD symptoms. J Am Acad Child Adolesc Psychiatry 2007; 46: 811–19. https://doi.org/10.1097/chi.0b013e3180547105Google Scholar
Cohen, J. A., Bukstein, O., Walter, H., et al. Practice parameter for the assessment and treatment of children and adolescents with posttraumatic stress disorder. J Am Acad Child Adolesc Psychiatry 2010; 49: 414–30. https://doi.org/10.1016/j.jaac.2009.12.020Google Scholar
Famularo, R., Kinscherff, R., Fenton, T. Propranolol treatment for childhood posttraumatic stress disorder, acute type. A pilot study. Am J Dis Child 1988; 142: 1244–7. http://www.ncbi.nlm.nih.gov/pubmed/3177336Google Scholar
Flynn, J. T., Daniels, S. R., Hayman, L. L., et al. Update: ambulatory blood pressure monitoring in children and adolescents: a scientific statement from the American Heart Association. Hypertension 2014; 63: 1116–35. https://doi.org/10.1161/HYP.0000000000000007Google Scholar
Flynn, J. T., Kaelber, D. C., Baker-Smith, C. M., et al. Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics 2017; 140: e20171904. https://doi.org/10.1542/peds.2017-1904Google Scholar
Jones, L. S., Gauger, L. L., Davis, J. N. Anatomy of brain alpha 1-adrenergic receptors: in vitro autoradiography with [125I]-heat. J Comp Neurol 1985; 231: 190–208. https://doi.org/10.1002/cne.902310207Google Scholar
Keeshin, B. R., Strawn, J. R. Treatment of children and adolescents with posttraumatic stress disorder (PTSD): a review of current evidence. Child Adolesc Psychopharmacol News 2012; 17: 5–10. https://doi.org/10.1080/15374416.2020.1823849Google Scholar
Keeshin, B. R., Strawn, J. R. Psychological and pharmacologic treatment of youth with posttraumatic stress disorder: an evidence-based review. Child Adolesc Psychiatr Clin N Am 2014; 23: 399–411. https://doi.org/10.1016/j.chc.2013.12.002Google Scholar
Keeshin, B. R., Strawn, J. R., Out, D., Granger, D. A., Putnam, F. W. Cortisol awakening response in adolescents with acute sexual abuse related posttraumatic stress disorder. Depress Anxiety 2014; 31: 107–14. https://doi.org/10.1002/da.22154Google Scholar
Keeshin, B. R., Strawn, J. R., Out, D., Granger, D. A., Putnam, F. W. Elevated salivary alpha amylase in adolescent sexual abuse survivors with posttraumatic stress disorder symptoms. J Child Adolesc Psychopharmacol 2015; 25: 344–50. https://doi.org/10.1089/cap.2014.0034Google Scholar
Keeshin, B. R., Ding, Q., Presson, A. P., Berkowitz, S. J., Strawn, J.R. Use of prazosin for pediatric PTSD-associated nightmares and sleep disturbances: a retrospective chart review. Neurol Ther 2017; 6: 247–57. https://doi.org/10.1007/s40120-017-0078-4Google Scholar
Pervanidou, P. Biology of post-traumatic stress disorder in childhood and adolescence. J Neuroendocrinol 2008; 20: 632–8. https://doi.org/10.1111/j.1365-2826.2008.01701.xGoogle Scholar
Pervanidou, P., Kolaitis, G., Charitaki, S., et al. The natural history of neuroendocrine changes in pediatric posttraumatic stress disorder (PTSD) after motor vehicle accidents: progressive divergence of noradrenaline and cortisol concentrations over time. Biol Psychiatry 2007; 62: 1095–102. https://doi.org/10.1016/j.biopsych.2007.02.008Google Scholar
Rosenberg, L., Rosenberg, M., Fuchs, H., et al. Does propranolol prevent symptoms of posttraumatic stress disorder (PTSD) in children with large burns? J Burn Care Res 2012; 33: S119. http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/767/CN-01010767/frame.htmlGoogle Scholar
Seedat, S., Stein, D. J., Ziervogel, C., et al. Comparison of response to a selective serotonin reuptake inhibitor in children, adolescents, and adults with posttraumatic stress disorder. J Child Adolesc Psychopharmacol 2002; 12: 37–46. https://doi.org/10.1089/10445460252943551Google Scholar
Stahl, S., Grady, M. M., Muntner, N. Stahl’s Essential Psychopharmacology: Neuroscientific Basis and Practical Applications, 5th edn. Cambridge, UK: Cambridge University Press, 2021.Google Scholar
Thombs, B. D., Bresnick, M. G., Magyar-Russell, G., Kim, T. J. Pediatr Crit Care Med 2006; 7: 498; author reply 498–9. https://doi.org/10.1089/10445460252943551Google Scholar